BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-7.91%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$118M
AUM Growth
+$118M
Cap. Flow
-$12.1M
Cap. Flow %
-10.3%
Top 10 Hldgs %
75.47%
Holding
54
New
–
Increased
13
Reduced
5
Closed
3

Top Buys

1
AXGN icon
Axogen
AXGN
$665K
2
PRTA icon
Prothena Corp
PRTA
$650K
3
BLUE
bluebird bio
BLUE
$626K
4
BDSX icon
Biodesix
BDSX
$504K
5
KPTI icon
Karyopharm Therapeutics
KPTI
$376K

Top Sells

1
AXDX
Accelerate Diagnostics
AXDX
$11.7M
2
SLNO icon
Soleno Therapeutics
SLNO
$1.05M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$984K
4
UTHR icon
United Therapeutics
UTHR
$903K
5
NBIX icon
Neurocrine Biosciences
NBIX
$788K

Sector Composition

1 Healthcare 94.79%
2 Energy 5.2%
3 Consumer Staples 0.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KPTI icon
26
Karyopharm Therapeutics
KPTI
$61.7M
$766K 0.65% 571,832 +280,500 +96% +$376K
CYTK icon
27
Cytokinetics
CYTK
$4.23B
$737K 0.63% 25,000 – –
TVTX icon
28
Travere Therapeutics
TVTX
$1.56B
$733K 0.62% 82,000 +42,000 +105% +$375K
DCGO icon
29
DocGo
DCGO
$153M
$693K 0.59% 130,000 +20,000 +18% +$107K
APLS icon
30
Apellis Pharmaceuticals
APLS
$3.48B
$685K 0.58% 18,000 +6,000 +50% +$228K
PTGX icon
31
Protagonist Therapeutics
PTGX
$3.67B
$634K 0.54% 38,000 – –
SILK
32
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$619K 0.53% 41,294 +21,294 +106% +$319K
PGNY icon
33
Progyny
PGNY
$2.04B
$612K 0.52% 18,000 +9,000 +100% +$306K
KNSA icon
34
Kiniksa Pharmaceuticals
KNSA
$2.48B
$521K 0.44% 30,000 – –
KALV icon
35
KalVista Pharmaceuticals
KALV
$678M
$385K 0.33% 40,000 – –
HALO icon
36
Halozyme
HALO
$8.56B
$382K 0.32% 10,000 – –
XENE icon
37
Xenon Pharmaceuticals
XENE
$2.98B
$342K 0.29% 10,000 – –
FOLD icon
38
Amicus Therapeutics
FOLD
$2.34B
$340K 0.29% 28,000 – –
STOK icon
39
Stoke Therapeutics
STOK
$1.08B
$335K 0.28% 85,000 – –
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.78B
$303K 0.26% 2,500 – –
ARVN icon
41
Arvinas
ARVN
$568M
$295K 0.25% 15,000 – –
XNCR icon
42
Xencor
XNCR
$580M
$248K 0.21% 12,300 – –
TSVT
43
DELISTED
2seventy bio
TSVT
$235K 0.2% 59,833 – –
CGEM icon
44
Cullinan Oncology
CGEM
$445M
$227K 0.19% 25,114 – –
KROS icon
45
Keros Therapeutics
KROS
$618M
$223K 0.19% 7,000 – –
GOSS icon
46
Gossamer Bio
GOSS
$562M
$174K 0.15% 209,088 +110,000 +111% +$91.6K
GTHX
47
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$173K 0.15% 120,000 +80,000 +200% +$115K
IFRX icon
48
InflaRx
IFRX
$108M
$149K 0.13% 50,000 – –
BCRX icon
49
BioCryst Pharmaceuticals
BCRX
$1.74B
$142K 0.12% 20,000 – –
NKTR icon
50
Nektar Therapeutics
NKTR
$568M
$16.7K 0.01% 28,000 – –
1
2
3